Practical implications of the ADNEX risk prediction model for diagnosis of ovarian cancer Post date 3 April 2024 ← We can progress sustainable healthcare by breaking silos and changing behaviours → Characterization of approval status, endpoints, results, and recommendations for oncology drug treatments from the NCCN